195 related articles for article (PubMed ID: 35614027)
1. Towards personalized treatment of T2N0 rectal cancer: A systematic review of long-term oncological outcomes of neoadjuvant therapy followed by local excision.
Peltrini R; Imperatore N; Di Nuzzo MM; Pellino G
J Gastroenterol Hepatol; 2022 Aug; 37(8):1426-1433. PubMed ID: 35614027
[TBL] [Abstract][Full Text] [Related]
2. Comparing neoadjuvant therapy followed by local excision to total mesorectal excision in the treatment of early stage rectal cancer: a systematic review and meta-analysis of randomised clinical trials.
Lynch P; Ryan OK; Donnelly M; Ryan ÉJ; Davey MG; Reynolds IS; Creavin B; Hanly A; Kennelly R; Martin ST; Winter DC
Int J Colorectal Dis; 2023 Nov; 38(1):263. PubMed ID: 37924372
[TBL] [Abstract][Full Text] [Related]
3. Chemoradiation and Local Excision Versus Total Mesorectal Excision for T2N0 Rectal Cancer: Comparison of Short- and Long-Term Outcomes From 2 Prospective Studies.
Lynn PB; Van der Valk MJM; Claassen YHM; Shi Q; Widmar M; Bastiaannet E; Van de Velde CJH; Garcia-Aguilar J
Ann Surg; 2023 Jan; 277(1):e96-e102. PubMed ID: 34225302
[TBL] [Abstract][Full Text] [Related]
4. Oncological outcomes of local excision compared with radical surgery after neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and meta-analysis.
Shaikh I; Askari A; Ourû S; Warusavitarne J; Athanasiou T; Faiz O
Int J Colorectal Dis; 2015 Jan; 30(1):19-29. PubMed ID: 25367179
[TBL] [Abstract][Full Text] [Related]
5. Oncologic Safety of Local Excision Compared With Total Mesorectal Excision for ypT0-T1 Rectal Cancer: A Propensity Score Analysis.
Jung SM; Yu CS; Park IJ; Kim TW; Kim JH; Yoon YS; Lim SB; Kim JC
Medicine (Baltimore); 2016 May; 95(20):e3718. PubMed ID: 27196490
[TBL] [Abstract][Full Text] [Related]
6. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
[TBL] [Abstract][Full Text] [Related]
7. Short- and long-term outcomes in ypT2 rectal cancer patients after neoadjuvant therapy and local excision: a multicentre observational study.
Peltrini R; Castiglioni S; Imperatore N; Ortenzi M; Rega D; Romeo V; Caracino V; Liberatore E; Basti M; Santoro E; Bracale U; Delrio P; Mucilli F; Guerrieri M; Corcione F
Tech Coloproctol; 2023 Jan; 27(1):53-61. PubMed ID: 36239872
[TBL] [Abstract][Full Text] [Related]
8. A Systematic Review of Local Excision After Neoadjuvant Therapy for Rectal Cancer: Are ypT0 Tumors the Limit?
Hallam S; Messenger DE; Thomas MG
Dis Colon Rectum; 2016 Oct; 59(10):984-97. PubMed ID: 27602930
[TBL] [Abstract][Full Text] [Related]
9. Local excision after neoadjuvant chemoradiotherapy versus total mesorectal excision: a case-matched study in 110 selected high-risk patients with rectal cancer.
Calmels M; Collard MK; Cazelles A; Frontali A; Maggiori L; Panis Y
Colorectal Dis; 2020 Dec; 22(12):1999-2007. PubMed ID: 32813899
[TBL] [Abstract][Full Text] [Related]
10. Oncologic outcomes of watch-and-wait strategy or surgery for low to intermediate rectal cancer in clinical complete remission after adjuvant chemotherapy: a systematic review and meta-analysis.
Tan S; Gao Q; Cui Y; Ou Y; Huang S; Feng W
Int J Colorectal Dis; 2023 Oct; 38(1):246. PubMed ID: 37787779
[TBL] [Abstract][Full Text] [Related]
11. Completion total mesorectal excision after neoadjuvant radiochemotherapy and local excision for rectal cancer.
Coco C; Delrio P; Rega D; Amodio LE; Pucciarelli S; Spolverato G; Belluco C; Lauretta A; Poggioli G; Rocco G; Bianco F; Marsanic P; Sica G; Tondolo V; Rizzo G;
Colorectal Dis; 2024 Feb; 26(2):281-289. PubMed ID: 38131642
[TBL] [Abstract][Full Text] [Related]
12. Local excision after neoadjuvant chemoradiotherapy for mid and low rectal cancer: a multicentric French study from the GRECCAR group.
Calmels M; Labiad C; Lelong B; Lefevre JH; Tuech JJ; Benoist S; Mège D; Denost Q; Panis Y
Colorectal Dis; 2023 Oct; 25(10):1973-1980. PubMed ID: 37679892
[TBL] [Abstract][Full Text] [Related]
13. Survival analysis of local excision vs total mesorectal excision for middle and low rectal cancer in pT1/pT2 stage and intermediate pathological risk.
Lai IL; You JF; Chern YJ; Tsai WS; Chiang JM; Hsieh PS; Hung HY; Yeh CY; Chiang SF; Lai CC; Tang RP; Chen JS; Hsu YJ
World J Surg Oncol; 2019 Dec; 17(1):212. PubMed ID: 31818295
[TBL] [Abstract][Full Text] [Related]
14. Local excision for ypT2 rectal cancer following preoperative chemoradiation therapy: it should not be justified.
Yang KM; Lim SB; Lee JL; Kim CW; Yoon YS; Park IJ; Yu CS; Kim JC
Int J Colorectal Dis; 2018 Apr; 33(4):487-491. PubMed ID: 29468352
[TBL] [Abstract][Full Text] [Related]
15. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
16. A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trial.
Garcia-Aguilar J; Shi Q; Thomas CR; Chan E; Cataldo P; Marcet J; Medich D; Pigazzi A; Oommen S; Posner MC
Ann Surg Oncol; 2012 Feb; 19(2):384-91. PubMed ID: 21755378
[TBL] [Abstract][Full Text] [Related]
17. Clinical T2N0 Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy plus Local Excision.
Suzuki T; Sadahiro S; Okada K; Miyakita H; Ogimi T; Chan LF; Kamei Y; Yamamoto S
Oncology; 2023; 101(3):166-172. PubMed ID: 36310019
[TBL] [Abstract][Full Text] [Related]
18. Systematic review and meta-analysis of long-term oncological outcomes of lateral lymph node dissection for metastatic nodes after neoadjuvant chemoradiotherapy in rectal cancer.
Kroon HM; Hoogervorst LA; Hanna-Rivero N; Traeger L; Dudi-Venkata NN; Bedrikovetski S; Kusters M; Chang GJ; Thomas ML; Sammour T
Eur J Surg Oncol; 2022 Jul; 48(7):1475-1482. PubMed ID: 35568607
[TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy of transanal local excision versus total mesorectal excision after neoadjuvant treatment for rectal cancer: A meta-analysis.
Lei Y; Lin L; Shao Q; Chen W; Liu G
PLoS One; 2023; 18(11):e0294510. PubMed ID: 37983236
[TBL] [Abstract][Full Text] [Related]
20. Surgical, oncological, and functional outcomes of local and radical resection after neoadjuvant chemotherapy or chemoradiotherapy for early- and mid-stage rectal cancer: a systematic review and meta-analysis.
Tan S; Ou Y; Huang S; Gao Q
Int J Colorectal Dis; 2023 May; 38(1):132. PubMed ID: 37193915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
